Clinical, in vitro, and in vivo evidence of WAPL as a novel cohesinopathy gene and phenotypic driver of 10q22.3q23.2 genomic disorder

This study identifies WAPL as a novel cohesinopathy gene causing a distinct developmental disorder and establishes it as the primary driver gene within the 10q22.3q23.2 genomic deletion syndrome, while demonstrating that PDS5A and PDS5B variants do not yield specific phenotypes and highlighting a critical dosage sensitivity threshold for WAPL function.

The Gist

Imagine your DNA isn't just a long, tangled string of instructions; it's a massive, complex library. For the library to work, the books (genes) need to be organized into specific sections, and the lights need to turn on only when a specific reader needs them.

Cohesin is the librarian who does the heavy lifting. It grabs loops of DNA, organizes them into neat little neighborhoods, and makes sure the right genes get turned on or off at the right time.

But a librarian can't just organize the books and leave them there forever. Sometimes, the books need to be moved, reorganized, or put back on the shelf. That's where WAPL comes in. Think of WAPL as the librarian's "reset button" or the "clean-up crew." Its job is to gently remove the cohesin loops so the DNA can breathe, change shape, and prepare for the next step.

This paper is about what happens when that "clean-up crew" (WAPL) is missing a few members.

The Big Discovery: A New Kind of "Librarian" Problem

Scientists have long known that if the main librarian (a protein called NIPBL) is broken, it causes a severe condition called Cornelia de Lange Syndrome. But they didn't know if the "clean-up crew" (WAPL) caused any problems in humans.

In this study, the researchers found 27 people with broken or missing WAPL genes. They discovered that these people share a specific set of challenges, which the authors are calling "WAPL Deficiency Syndrome."

What does it look like?

• The "Brain Fog": Most people have mild to moderate delays in learning, walking, or talking. It's not as severe as the main librarian syndrome, but it's definitely noticeable.
• The "Blueprint" Glitches: Just like a house built with a faulty blueprint, these individuals often have physical differences. Some have distinct facial features, heart issues, or "clubfoot" (where the foot is turned inward).
• The "Reset" Failure: Because WAPL is the reset button, when it's broken, the DNA loops stay stuck. This confuses the cell's instruction manual, leading to the developmental issues mentioned above.

The "Missing Piece" Mystery

The researchers also noticed something interesting. There is a known "genomic disorder" (a large chunk of missing DNA) on chromosome 10. People who are missing this chunk often have the same problems as the people with broken WAPL genes.

For years, doctors knew where the problem was (the missing chunk), but they didn't know which specific gene inside that chunk was the culprit.

• The Analogy: Imagine a whole neighborhood is missing, and we know the missing houses cause traffic jams. But we don't know which specific house is the traffic light causing the jam.
• The Solution: By comparing the people with the missing chunk to the people with the broken WAPL gene, the scientists proved that WAPL is the traffic light. It is the main driver of the problems in that specific missing chunk of DNA.

Testing the Theory: The Mouse and the Stem Cell Lab

To be sure, the scientists didn't just look at people; they built models to test their theory.

1. The Human Stem Cell Lab: They took human stem cells (the "blank slate" cells that can become anything) and used a molecular pair of scissors (CRISPR) to break the WAPL gene.

   • Result: When they turned these cells into neurons (brain cells), the genes that were supposed to be quiet got loud, and the ones that should be loud got quiet. This confirmed that breaking WAPL messes up the brain's instruction manual.

2. The Mouse Models: They created mice with broken WAPL genes.

   • The "50% Crew" (Heterozygous): Mice with half the normal amount of WAPL were born healthy but were a bit smaller. As adults, they were actually better at some tasks (like running on a wheel) but had trouble with long-term memory (like remembering where a hidden platform was in a pool of water). This mirrors the human experience: they can function, but they struggle with learning and memory.
   • The "25% Crew" (Hypomorphic): When the researchers reduced WAPL to just a quarter of normal levels, the mice didn't survive birth. They had severe birth defects.
   • The Lesson: There is a "Goldilocks zone" for WAPL. You need a lot of it to survive, but having half is enough to live, just with some developmental bumps.

What About the Other Clean-Up Crew Members?

WAPL works with two partners, PDS5A and PDS5B. The scientists looked at people with broken versions of these genes too.

• The Result: While these people were also sick, their symptoms were all over the map. One person had heart issues, another had learning delays, another had seizures. They didn't form a clear, recognizable pattern like the WAPL group.
• Conclusion: WAPL seems to be the star of the show. PDS5A and PDS5B might be important, but they don't seem to cause a single, specific syndrome on their own.

Why Does This Matter?

This paper is a big deal for three reasons:

1. New Diagnosis: Doctors now know to look for WAPL mutations in patients with developmental delays and heart/foot issues. This means families can finally get a name for what's happening to their children.
2. Solving a Mystery: It solved the puzzle of the "10q deletion" syndrome, identifying WAPL as the main culprit.
3. Understanding the Body: It teaches us that the "reset button" of our DNA is just as important as the "organizer." If you can't reset the loops, the whole system gets confused.

In short: This study found a new genetic condition caused by a broken "DNA reset button." It explains why some people struggle with learning and physical development, and it helps doctors diagnose and understand these rare conditions much better.

Technical Summary

1. Problem Statement

Cohesin is a fundamental protein complex responsible for 3D chromosome folding, topologically associating domain (TAD) formation, and gene regulation via DNA loop extrusion. Mutations in cohesin loading factors (e.g., NIPBL) and core subunits cause well-characterized Mendelian disorders known as "cohesinopathies," most notably Cornelia de Lange syndrome (CdLS). However, the clinical relevance of cohesin release factors—specifically WAPL and its binding partners PDS5A and PDS5B—remained unexplored. While these factors are essential for resetting the cohesin cycle, it was unknown if their disruption causes human disease. Additionally, the 10q22.3q23.2 genomic region, which contains WAPL, is subject to recurrent deletions and duplications associated with neurodevelopmental disorders (NDDs), but the specific "driver gene" within this locus had not been confirmed.

2. Methodology

The authors employed a multi-modal approach combining clinical genetics, large-scale genomic epidemiology, cellular modeling, and animal studies:

• Clinical Cohort & Phenotyping:
  • Identified and deeply phenotyped 27 individuals with heterozygous, predicted damaging variants in WAPL, 8 in PDS5A, and 8 in PDS5B.
  • Analyzed inheritance patterns (de novo vs. inherited) and clinical features (developmental delay, dysmorphism, organ malformations).
• Genomic Association Studies:
  • rCNV Analysis: Screened a dataset of ~1 million individuals (458k cases, 492k controls) for 10q22.3q23.2 deletions/duplications to define the genomic disorder (GD) phenotype.
  • Exome Burden Analysis: Utilized the "DDD" (31k trios) and "NDD" (38k trios) datasets with a Bayesian transmission and de novo association (TADA) framework to test for statistical enrichment of variants in WAPL, PDS5A, and PDS5B among NDD cases.
• Epigenetic Profiling:
  • Applied EpiSign™ analysis to peripheral blood DNA to determine if WAPL/PDS5 variants produce a distinct DNA methylation episignature compared to controls and CdLS.
• In Vitro Disease Modeling (CRISPR):
  • Generated isogenic human induced pluripotent stem cells (iPSCs) and induced glutamatergic neurons (iNs) using CRISPR-Cas9.
  • Created models for: (1) Heterozygous WAPL frameshift indels (WAPL+/-); (2) Heterozygous 10q22.3q23.2 deletions (10q del); (3) Heterozygous 10q22.3q23.2 duplications (10q dup).
  • Performed RNA-seq to identify differentially expressed genes (DEGs) and pathway enrichment.
• In Vivo Mouse Models:
  • Characterized Wapl+/- mice (50% expression) for neonatal and adult behavioral phenotypes (motor skills, memory, anxiety).
  • Analyzed Wapl^Flox/- compound heterozygotes (25% expression) via micro-CT to assess embryonic lethality and structural defects.

3. Key Contributions

• Discovery of WAPL Deficiency Syndrome: Established WAPL as a novel haploinsufficient disease gene causing a distinct neurodevelopmental disorder.
• Driver Gene Identification: Confirmed WAPL as the primary driver gene responsible for the phenotypic features of the 10q22.3q23.2 genomic deletion syndrome.
• Dosage Sensitivity Thresholds: Defined a critical dosage threshold for WAPL in mice, demonstrating that 50% expression is viable with mild deficits, while 25% expression leads to lethality and severe birth defects.
• Differentiation of Cohesin Release Factors: Demonstrated that while WAPL variants cause a coherent syndrome, variants in its partners PDS5A and PDS5B do not yet form a unified Mendelian syndrome, suggesting functional divergence or redundancy.

4. Key Results

A. Clinical Phenotypes

• WAPL: 27 cases identified. The majority of variants were de novo. The phenotype is characterized by mild-to-moderate developmental delay/intellectual disability (DD/ID), craniofacial dysmorphism (retrognathia, high columella), behavioral issues, and organ malformations (notably clubfoot and congenital heart defects).
• PDS5A/PDS5B: 8 cases each. While associated with morbidity and NDDs, the phenotypes were heterogeneous and did not coalesce into a specific syndromic pattern like WAPL.
• 10q Deletion: Analysis of 68 carriers (41 from cohort, 27 from literature) confirmed a phenotype overlapping significantly with WAPL point mutations (NDD, dysmorphism, musculoskeletal, and cardiac defects), supporting WAPL as the driver.

B. Molecular & Epigenetic Findings

• Methylation: A distinct DNA methylation episignature was identified for WAPL truncating variants combined with 10q deletions, but not for WAPL missense variants alone. This signature is distinct from CdLS.
• Transcriptomics:
  • WAPL+/- and 10q del models showed highly correlated transcriptional profiles (Spearman correlation > 0.6) in both iPSCs and neurons.
  • Enriched pathways included embryo development (in iPSCs) and cell-cell adhesion (in neurons).
  • No dosage compensation (buffering) was observed for genes within the 10q region; expression levels scaled linearly with copy number.

C. In Vivo Mouse Phenotypes

• 50% Dosage (Wapl+/-): Mice were viable and fertile. They exhibited:
  • Neonatal: Mildly reduced body weight; transiently superior performance in righting reflex and geotaxis compared to wild-type (WT).
  • Adult: Superior spatial short-term memory (Y-maze) and motor coordination (rotarod), but poorer long-term learning/memory (Morris Water Maze). No significant anxiety or motor deficits were observed.
• 25% Dosage (Wapl^Flox/-): Resulted in perinatal lethality. Surviving embryos showed discrete birth defects: delayed lung maturation, renal agenesis/hypoplasia, and missing medullary facial nuclei. This establishes a dosage liability threshold between 25% and 50%.

D. Statistical Associations

• Large-scale exome burden analysis confirmed a statistically significant association between WAPL variants and NDDs (FDR = 5.14e-3), whereas PDS5A and PDS5B did not reach significance.
• WAPL showed the highest constraint (LOEUF = 0.04) among genes in the 10q22.3q23.2 region.

5. Significance

• Novel Cohesinopathy: This study expands the spectrum of cohesinopathies beyond the loading complex (NIPBL/MAU2) and core ring (SMC1A/SMC3/RAD21) to include the release factor WAPL. It proves that disrupting the removal of cohesin is as pathogenic as disrupting its loading.
• Genomic Disorder Resolution: It resolves the "driver gene" mystery of the 10q22.3q23.2 deletion syndrome, shifting clinical focus to WAPL haploinsufficiency for genetic counseling and diagnosis.
• Dosage Sensitivity: The findings highlight that cohesin balance is bidirectionally dosage-sensitive. While NIPBL loss causes severe CdLS, WAPL loss causes a milder, yet distinct, syndrome, and the mouse models suggest a therapeutic window where modulating cohesin levels might be tolerated.
• Mechanistic Insight: The lack of a methylation signature for missense WAPL variants suggests that the pathomechanism may differ between truncating and missense mutations, or that missense variants retain partial function sufficient to maintain the epigenetic status quo.

In conclusion, the paper provides comprehensive evidence that WAPL is a critical human disease gene, defining a new clinical entity and clarifying the molecular basis of a recurrent genomic disorder.